MDS to Present at the UBS Global Life Sciences Conference
18 Settembre 2006 - 3:00PM
PR Newswire (US)
TORONTO, Sept. 18 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;
NYSE: MDZ), a leading provider of products and services to the
global life sciences markets, announced that Stephen P. DeFalco,
President and CEO, will present at the UBS Global Life Sciences
Conference in New York City on Tuesday, September 26th, at 4:30pm
(EST). Interested parties may access the webcast starting at 7:30pm
on September 26th by visiting the "Latest News" section of the MDS
home page at http://www.mdsinc.com/. An audio archive of the
presentation will also be available under "Webcasts &
Presentations" in our "For Investors" section until October 28,
2006. MDS Inc. is a global life sciences company that provides
market-leading products and services that our customers need for
the development of drugs and the diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radio
therapeutics, and analytical instruments. MDS has more than 8,800
highly skilled people in 28 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Vice-President,
Investor Relations and External Communications, (416) 675-6777 ext.
4721,
Copyright